…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …
vemurafenib
This drug is selected. Its supporting articles are shown below.
Articles mentioning vemurafenib
5 articles · page 1 of 1…TEZO, atezolizumab; BINI, binimetinib; COBI, cobimetinib; ENCO, encorafenib; ESS, effective sample size; DAB, dabrafenib; NIVO, nivolumab; …
…esized that combining the STING agonist ADU-S100 with the BRAFi vemurafenib would synergistically augment NK cell cytotoxicity and promote …
…rare non-Langerhans histiocytosis affecting multiple systems.As vemurafenib was unavailable in Mexico, pegylated interferon alpha (PEG-IFN-…
…(NIVO+RELA) to BRAF/MEK inhibitors, we compared its efficacy to dabrafenib+trametinib (DAB+TRAM), encorafenib+binimetinib (ENCO+BINI), vem…